Muse+TriposScore: a ligand-based de novo design approach
2011
Muse: A New Approach to Drug Design
publication
Evidence: moderate
Author Information
Author(s): Bös F, Uhrig U, Masek BB, Damewood JR
Primary Institution: Tripos International
Hypothesis
Can a multi-parameter ligand-based de novo design approach improve drug discovery?
Conclusion
The Muse approach successfully generates novel drug structures that are validated against known active compounds.
Supporting Evidence
- The Muse approach incorporates molecular shape and fingerprint similarity.
- Retrospective studies show it can generate novel ideas for drug design.
- It can modify existing molecular frameworks or create new templates.
Takeaway
This study shows a new way to create drugs by changing existing ones to make them better. It's like taking a toy and making it cooler by adding new parts.
Methodology
The study used an evolutionary algorithm to generate new drug structures based on user-defined scoring functions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website